If 2020 resulted in extreme vaccine inequities, 2021 appears to stand witness to the ways in which technology transfer is being restrained by exclusivity fuelled by commercial and political considerations. This is not only widening the gulf between those who have COVID-19 vaccines now, but will also expand inequities in the access to medical products in the future, by restricting the way technology will be shared.
We have reported on how massive political capital is being invested in continuing with industry-determined technology transfer arrangements even as the world faces acute scarcity in the access to medical products for COVID-19.
In this story we connect the dots on seemingly disparate events that are coming together to shape the discussions on technology transfer to enable production of COVID-19 medical products – a key frontier to conquer, if the world must turn the corner in this pandemic.
Image credit: Pexels
To read the full story, you will need to sign up to our newsletter. While our edition on Tuesdays, The Weekly Primer is free, our exclusive analyses published in The Friday Deep Dives are behind a paywall.
Questions? Get in touch with us. [firstname.lastname@example.org]